Found: 16
Select item for more details and to access through your institution.
Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2010, v. 48, n. 10, p. 1481, doi. 10.1515/CCLM.2010.278
- By:
- Publication type:
- Article
Critical Involvement of the ATM-Dependent DNA Damage Response in the Apoptotic Demise of HIV-1- Elicited Syncytia.
- Published in:
- PLoS ONE, 2008, v. 3, n. 6, p. 1, doi. 10.1371/journal.pone.0002458
- By:
- Publication type:
- Article
A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 9, p. 1395, doi. 10.3390/biom11091395
- By:
- Publication type:
- Article
Prognostic Value of the Immunological Subtypes of Adolescent and Adult T-Cell Lymphoblastic Lymphoma; an Ultra-High-Risk Pro-T/CD2(−) Subtype.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1911, doi. 10.3390/cancers13081911
- By:
- Publication type:
- Article
Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1647, doi. 10.3390/cancers11111647
- By:
- Publication type:
- Article
Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal.
- Published in:
- BMC Genomics, 2009, v. 10, p. 261, doi. 10.1186/1471-2164-10-261
- By:
- Publication type:
- Article
The sensitivity of BRCA1 mutation carriers to ionising radiation: questions of methodology.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection.
- Published in:
- Cellular Oncology (2211-3428), 2017, v. 40, n. 5, p. 529, doi. 10.1007/s13402-017-0334-8
- By:
- Publication type:
- Article
PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271539
- By:
- Publication type:
- Article
Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 115, doi. 10.1159/000093002
- By:
- Publication type:
- Article
Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors.
- Published in:
- Genes, 2022, v. 13, n. 9, p. 1611, doi. 10.3390/genes13091611
- By:
- Publication type:
- Article
Analysis of Newly Identified and Rare Synonymous Genetic Variants in the RET Gene in Patients with Medullary Thyroid Carcinoma in Polish Population.
- Published in:
- Endocrine Pathology, 2017, v. 28, n. 3, p. 198, doi. 10.1007/s12022-017-9487-2
- By:
- Publication type:
- Article
Systemic inflammation as a confounding factor in cancer biomarker discovery and validation.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.
- Published in:
- Medical Oncology, 2014, v. 31, n. 8, p. 1, doi. 10.1007/s12032-014-0109-2
- By:
- Publication type:
- Article
Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma.
- Published in:
- Medical Oncology, 2012, v. 29, n. 3, p. 2143, doi. 10.1007/s12032-011-0010-1
- By:
- Publication type:
- Article
A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival.
- Published in:
- Medical Oncology, 2011, v. 28, n. 1, p. 194, doi. 10.1007/s12032-009-9403-9
- By:
- Publication type:
- Article